Popular
RF Microneedling Safety: Reframing the Conversation with Leading Experts Ch. 2
Modern AestheticsRF Microneedling Safety: Reframing the Conversation with Leading Experts Ch. 2
Konika Patel Schallen, MD
Gilly Munavalli, MD
James Newman, MD, FACS
Scott Gerrish, DO
Sara Hogan, MD, FAAD
Cameron Rokhsar, MD
RF Microneedling Safety: Reframing the Conversation with Leading Experts Ch. 5
Modern AestheticsRF Microneedling Safety: Reframing the Conversation with Leading Experts Ch. 5
Konika Patel Schallen, MD
Gilly Munavalli, MD
James Newman, MD, FACS
Scott Gerrish, DO
Sara Hogan, MD, FAAD
Cameron Rokhsar, MD
RF Microneedling Safety: Reframing the Conversation with Leading Experts Ch. 4
Modern AestheticsRF Microneedling Safety: Reframing the Conversation with Leading Experts Ch. 4
Konika Patel Schallen, MD
Gilly Munavalli, MD
James Newman, MD, FACS
Scott Gerrish, DO
Sara Hogan, MD, FAAD
Cameron Rokhsar, MD
SPIRIT-HF: Does Spironolactone Improve Outcomes in HFpEF and HFmrEF?
CardiologySPIRIT-HF: Does Spironolactone Improve Outcomes in HFpEF and HFmrEF?
Muthiah Vaduganathan, MD, MPH
Chairperson’s Perspective: Reframing First-Line and Subsequent Care in Advanced Urothelial Carcinoma – Clinical Implications of the Updated NCCN Guidelines
CME/CEChairperson’s Perspective: Reframing First-Line and Subsequent Care in Advanced Urothelial Carcinoma – Clinical Implications of the Updated NCCN Guidelines
Jean Hoffman-Censits, MD
Finerenone in HFpEF: Key Insights From ESC HF
CardiologyFinerenone in HFpEF: Key Insights From ESC HF
John W. Ostrominski, MD, MPH
Programs
RF Microneedling Safety: Reframing the Conversation with Leading Experts Ch. 2
Modern AestheticsRF Microneedling Safety: Reframing the Conversation with Leading Experts Ch. 2
Konika Patel Schallen, MD
Gilly Munavalli, MD
James Newman, MD, FACS
Scott Gerrish, DO
Sara Hogan, MD, FAAD
Cameron Rokhsar, MD
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
CME/CE Virtual EventPrecision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
July 08, 2026
06:00 PM - 07:30 PM ET
Treatment Patterns and MRA Use in Patients with HFmrEF/HFpEF: Insights From FRAME-HF and IRIS HF
CardiologyTreatment Patterns and MRA Use in Patients with HFmrEF/HFpEF: Insights From FRAME-HF and IRIS HF
Andrew Patrick Ambrosy, MD, MPH
SPIRIT-HF: Does Spironolactone Improve Outcomes in HFpEF and HFmrEF?
CardiologySPIRIT-HF: Does Spironolactone Improve Outcomes in HFpEF and HFmrEF?
Muthiah Vaduganathan, MD, MPH
Chairperson’s Perspective: Reframing First-Line and Subsequent Care in Advanced Urothelial Carcinoma – Clinical Implications of the Updated NCCN Guidelines
CME/CEChairperson’s Perspective: Reframing First-Line and Subsequent Care in Advanced Urothelial Carcinoma – Clinical Implications of the Updated NCCN Guidelines
Jean Hoffman-Censits, MD
Grooving Through Lipid Management: A New Rhythm in ASCVD Risk Reduction
CME/CEGrooving Through Lipid Management: A New Rhythm in ASCVD Risk Reduction
Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Viet Le, DMSc, MPAS, PA-C, FACC, FAHA, HF-Cert
Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC
Pam R. Taub, MD, FACC, FASPC
Clinical Practice
Integrating Patient Perspectives in Dermatologic Care
DermConsultIntegrating Patient Perspectives in Dermatologic Care
Mona Shahriari MD, FAAD
Linda Stein Gold, MD
Jennifer Soung, MD
DESTINY-Breast05 Findings Lead to New Indication for Trastuzumab Deruxtecan as Adjuvant Treatment for Residual Invasive Disease
Oncology and HematologyDESTINY-Breast05 Findings Lead to New Indication for Trastuzumab Deruxtecan as Adjuvant Treatment for Residual Invasive Disease
Sara A. Hurvitz, MD, FACP
Data Meets Decision: Expert Approaches to Perioperative Immunotherapy in LA HNSCC
CME/CE Virtual EventData Meets Decision: Expert Approaches to Perioperative Immunotherapy in LA HNSCC
June 17, 2026
04:30 PM - 05:15 PM CEST
TROPION-Breast02: Evidence for the Approval of Datopotamab Deruxtecan for Patients With mTNBC Ineligible for Immunotherapy
Oncology and HematologyTROPION-Breast02: Evidence for the Approval of Datopotamab Deruxtecan for Patients With mTNBC Ineligible for Immunotherapy
Tiffany Traina, MD, FASCO
Case Challenges in Systemic Mastocytosis: Clinical Insights From the Expert Roundtable
CME/CECase Challenges in Systemic Mastocytosis: Clinical Insights From the Expert Roundtable
Carole Bitar, MD, FAAD
Matthew P. Giannetti, MD
Benjamin Ungar, MD
Doctors Lounge
Inside Medical Affairs: MSL Insights on AI, Strategy, and Impact
MAPSChatsInside Medical Affairs: MSL Insights on AI, Strategy, and Impact
Matt Birnholz, MD
Brandon Young, PhD
Collaboration in Medical Affairs: Increasing Value and Impact
MAPSChatsCollaboration in Medical Affairs: Increasing Value and Impact
Matt Birnholz, MD
Renu Juneja, PhD
Combatting Challenges & Health Disparities in Colorectal Cancer Care
Project Oncology®Combatting Challenges & Health Disparities in Colorectal Cancer Care
Jacob Sands, MD
Edith Mitchell, MD, MACP, FCPP, FRCP
Engaging Patients and Caregivers About Digital Therapeutics
Medical Industry FeatureEngaging Patients and Caregivers About Digital Therapeutics
Charles Turck, PharmD, BCPS, BCCCP
Maggie Emerson, DNP, APRN, PMHNP-BC
Turning Insight into Action: The Expanding Role of Medical Affairs
MAPSChatsTurning Insight into Action: The Expanding Role of Medical Affairs
Matt Birnholz, MD
Michael DeLuca, PharmD, MBA, MSRA
The Changing Landscape of CRC Screening and Prevention
On the Frontlines of Colorectal CancerThe Changing Landscape of CRC Screening and Prevention
Ryan Quigley
Samuel Muench, MD
CME
FXIa Remix! Keeping the Flow Without Missing a Beat
CME/CEFXIa Remix! Keeping the Flow Without Missing a Beat
Mike Sharma, MD, MSc, FRCPC
Ashkan Shoamanesh, MD
Brian Mac Grory, MB, BCh BAO, MRCP, FAHA, FANA
Sjögren’s Myth Busters: Can You Detect Fact from Fiction on Emerging Therapies?
CME/CESjögren’s Myth Busters: Can You Detect Fact from Fiction on Emerging Therapies?
Chadwick R. Johr, MD
Optimizing Iron Deficiency Management in CKD: IV Iron Replacement Therapy Amid the Latest KDIGO Guidelines
NephrologyOptimizing Iron Deficiency Management in CKD: IV Iron Replacement Therapy Amid the Latest KDIGO Guidelines
Brendon Neuen, MBBS, PhD
Chairperson’s Perspective: HER2 in Solid Tumors – From Pathology to Personalized Treatment Plans
CME/CEChairperson’s Perspective: HER2 in Solid Tumors – From Pathology to Personalized Treatment Plans
Kathleen N. Moore, MD, MS
Decision in Context: A Practical Framework for Sequencing Systemic and CNS Therapies in Brain Metastases
CME/CEDecision in Context: A Practical Framework for Sequencing Systemic and CNS Therapies in Brain Metastases
Barbara O'Brien, MD
- CME/CE In-Person & Virtual Event
Treating Outside the Box: New Pathways to Retinal Vascular Stability
July 17, 2026
Montreal
Industry Feature
Identifying and Managing Adult Patients with Chronic Immune Thrombocytopenia
Medical Industry FeatureIdentifying and Managing Adult Patients with Chronic Immune Thrombocytopenia
Sandhya Panch, MD, MPH
Ocular Management in PROC: Insights on Collaborative Care Across Practice Settings
Project Oncology®Ocular Management in PROC: Insights on Collaborative Care Across Practice Settings
Jennifer Caudle, DO, FACOFP
Ida Micaily, MD
Jeffrey Varanelli, OD
The Corticosteroid Journey in PMR: Understanding the Patient Experience
Medical Industry FeatureThe Corticosteroid Journey in PMR: Understanding the Patient Experience
Charles Turck, PharmD, BCPS, BCCCP
Rodney Daniel, MD
Grace C Wright, MD, PhD, FACR
Evolving Treatment Approaches in EGFRm NSCLC
Medical Industry FeatureEvolving Treatment Approaches in EGFRm NSCLC
Jennifer Caudle, DO, FACOFP
Hossein Borghaei, MS, DO
Debunking Five Misconceptions in Agitation in Alzheimer’s Dementia
Medical Industry FeatureDebunking Five Misconceptions in Agitation in Alzheimer’s Dementia
Clay Jackson, MD
Amita Patel, MD, CMD
Quick Takes in ATTR-CM: Symptoms and Comorbidities
Medical Industry FeatureQuick Takes in ATTR-CM: Symptoms and Comorbidities
Joshua Mitchell, MD, FACC